These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37643325)

  • 21. miRNA-103: molecular link between insulin resistance and nonalcoholic fatty liver disease.
    Xu Q; Li Y; Shang YF; Wang HL; Yao MX
    World J Gastroenterol; 2015 Jan; 21(2):511-6. PubMed ID: 25593466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating miR-29b positively correlates with non-alcoholic fatty liver disease in a Chinese population.
    He Z; Yang JJ; Zhang R; Li HT; Wu L; Jiang F; Jia WP; Hu C
    J Dig Dis; 2019 Apr; 20(4):189-195. PubMed ID: 30756471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer.
    Yau TO; Wu CW; Tang CM; Chen Y; Fang J; Dong Y; Liang Q; Ng SS; Chan FK; Sung JJ; Yu J
    Oncotarget; 2016 Jan; 7(2):1559-68. PubMed ID: 26621842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting Nonalcoholic Fatty Liver Disease through a Panel of Plasma Biomarkers and MicroRNAs in Female West Virginia Population.
    Pillai SS; Lakhani HV; Zehra M; Wang J; Dilip A; Puri N; O'Hanlon K; Sodhi K
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum biomarkers combined with ultrasonography for early diagnosis of non-alcoholic fatty liver disease confirmed by magnetic resonance spectroscopy.
    Qian LL; Wu L; Zhang L; Zhang J; Zhou J; Li YH; Fang QC; Li HT; Jia WP
    Acta Pharmacol Sin; 2020 Apr; 41(4):554-560. PubMed ID: 31776449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease.
    Miyaaki H; Ichikawa T; Kamo Y; Taura N; Honda T; Shibata H; Milazzo M; Fornari F; Gramantieri L; Bolondi L; Nakao K
    Liver Int; 2014 Aug; 34(7):e302-7. PubMed ID: 24313922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Association between Non-Alcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis with Serological Vitamin B12 Markers: Results from the NHANES 1999-2004.
    Li L; Huang Q; Yang L; Zhang R; Gao L; Han X; Ji L; Zou X
    Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study.
    Zarrinpar A; Gupta S; Maurya MR; Subramaniam S; Loomba R
    Gut; 2016 Sep; 65(9):1546-54. PubMed ID: 26002934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating microRNA‑135a‑3p in serum extracellular vesicles as a potential biological marker of non‑alcoholic fatty liver disease.
    Jiang H; Qian Y; Shen Z; Liu Y; He Y; Gao R; Shen M; Chen S; Fu Q; Yang T
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33955511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1.
    Ao R; Wang Y; Tong J; Wang BF
    Med Sci Monit; 2016 Oct; 22():3804-3819. PubMed ID: 27756894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR.
    Sun C; Huang F; Liu X; Xiao X; Yang M; Hu G; Liu H; Liao L
    Int J Mol Med; 2015 Mar; 35(3):847-53. PubMed ID: 25605429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between a non-invasive hepatic fibrosis score and urolithiasis among non-alcoholic fatty liver disease (NAFLD) patients in China: a cross-sectional study.
    Qin S; Wang J; Zhou C; Zhang Y; Xu Y; Wang X; Wang S
    BMJ Open; 2019 Aug; 9(8):e027702. PubMed ID: 31471434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.
    Lu ZY; Cen C; Shao Z; Chen XH; Xu CF; Li YM
    World J Gastroenterol; 2016 Feb; 22(5):1884-90. PubMed ID: 26855548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
    Long JK; Dai W; Zheng YW; Zhao SP
    Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical value of miR-135 and miR-20a combined with multi-detector computed tomography in the diagnosis of gastric cancer.
    Han W; Bu X; Liu Y; Liu F; Ren Y; Cui Y; Kong S
    World J Surg Oncol; 2021 Sep; 19(1):283. PubMed ID: 34537058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating miRNAs associated with nonalcoholic fatty liver disease.
    Atic AI; Thiele M; Munk A; Dalgaard LT
    Am J Physiol Cell Physiol; 2023 Feb; 324(2):C588-C602. PubMed ID: 36645666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease.
    Xu Y; Zhu Y; Hu S; Pan X; Bawa FC; Wang HH; Wang DQ; Yin L; Zhang Y
    Mol Metab; 2021 Sep; 51():101244. PubMed ID: 33930596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of microRNAs in immunopathogenesis of non-alcoholic fatty liver disease revealed by integrated analysis of microRNA and mRNA expression profiles.
    Zhang YJ; Hu Y; Li J; Chi YJ; Jiang WW; Zhang F; Liu YL
    Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):65-79. PubMed ID: 28119261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum immunoreactive collagen IV detected by monoclonal antibodies as a marker of severe fibrosis in patients with non-alcoholic fatty liver disease.
    Aida Y; Abe H; Tomita Y; Nagano T; Seki N; Sugita T; Itagaki M; Ishiguro H; Sutoh S; Aizawa Y
    J Gastrointestin Liver Dis; 2015 Mar; 24(1):61-8. PubMed ID: 25822435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.